No valuation for VenoStent is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($22.8M) and the funding record below are the closest available signals.
- ·The complete investor list: 30 names
- ·Watch VenoStent: the Monday email on marks, rounds and moves
VenoStent funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2026 | Early Stage VC | $10.0M | ▮ | ▮ |
| Jul 2023 | Early Stage VC | $16.1M | ▮ | ▮ |
Membership and data by Private Market View
How much has VenoStent raised?
VenoStent has raised $22.8 million across 2 recorded rounds since 2023. The largest was a $16.1 million early-stage round in Jul 2023; the most recent was a $10 million early-stage round in Apr 2026.
VenoStent has filed 2 Form Ds with the SEC since 2023, most recently in May 2026 ($10 million sold to 29 investors).
How VenoStent's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For VenoStent, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about VenoStent
- How much has VenoStent raised?
- VenoStent has raised $22.8M in total funding across 2 recorded rounds.
- When did VenoStent last raise?
- VenoStent last raised in Apr 2026 (Early Stage VC), raising $10.0M.